« Go Back


A Global Plan to Defend Against the Future's Deadliest Diseases

$460 million will go toward developing vaccines that prevent outbreaks like Ebola from taking the world by surprise.

The closing days of 2016 brought great news: The world now has an Ebola vaccine that’s 100 percent effective at preventing infections from the strain behind the recent west African outbreak...

Read more

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Marc Gurwith, MD, JD
Vice President of Clinical Affairs

Marc was Chief Medical Officer at Paxvax from 2007 to 2015, and Senior Vice President, Medical Affairs and Chief Medical Officer at Vaxgen from 2001-2007. In these two positions Marc ran clinical trials for vaccines aimed at influenza, anthrax and HIV. Marc has held similar positions at Genelabs, Sequus, Boeheringer-Mannheim and Wyeth Ayerst. Marc received his BA. magna cum laude from Yale, his M.D. cum laude from Harvard and his J.D. from Temple. Marc has authored over 100 scientific journal articles.

read more